Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Occidental Petroleum
OXY
5
Louisiana-Pacific
LPX
CA Stock MarketDetailed Quotes
NGEN NervGen Pharma Corp
- 3.540
- -0.050-1.39%
15min DelayMarket Closed May 9 16:00 ET
251.30MMarket Cap-9.83P/E (TTM)
3.570High3.500Low40.66KVolume3.560Open3.590Pre Close144.12KTurnover3.75052wk High0.07%Turnover Ratio70.99MShares1.65052wk Low-0.36EPS TTM208.88MFloat Cap3.980Historical HighLossP/E (Static)59.01MShs Float0.800Historical Low-0.36EPS LYR1.95%Amplitude--Dividend TTM98.33P/B1Lot Size--Div YieldTTM
NervGen Pharma Corp Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 40.25%24.93M | 39.61%6.81M | 109.51%7.16M | 25.80%6M | 5.36%4.97M | -22.79%17.78M | -28.15%4.87M | -30.62%3.42M | -24.45%4.77M | -5.75%4.72M |
| Selling and administrative expenses | -4.71%9.18M | 1.49%2.21M | 9.33%2.79M | -31.83%2.2M | 18.12%1.97M | 51.96%9.63M | 29.91%2.18M | 48.98%2.55M | 108.99%3.23M | 19.20%1.67M |
| -General and administrative expense | -4.71%9.18M | 1.49%2.21M | 9.33%2.79M | -31.83%2.2M | 18.12%1.97M | 51.96%9.63M | 29.91%2.18M | 48.98%2.55M | 108.99%3.23M | 19.20%1.67M |
| Research and development costs | 95.44%15.73M | 72.01%4.59M | 421.08%4.36M | 150.19%3.8M | -1.65%2.97M | -51.57%8.05M | -47.48%2.67M | -73.71%837.57K | -68.00%1.52M | -16.11%3.02M |
| Depreciation amortization depletion | -71.59%28K | -92.45%1.86K | -97.19%703 | -95.60%1.08K | 0.17%24.36K | 34.36%98.57K | 1.47%24.67K | 2.89%25.02K | 3.26%24.56K | 2,467.69%24.32K |
| -Depreciation and amortization | -71.59%28K | -92.45%1.86K | -97.19%703 | -95.60%1.08K | 0.17%24.36K | 34.36%98.57K | 1.47%24.67K | 2.89%25.02K | 3.26%24.56K | 2,467.69%24.32K |
| Operating profit | -40.25%-24.93M | -39.61%-6.81M | -109.51%-7.16M | -25.80%-6M | -5.36%-4.97M | 22.79%-17.78M | 28.15%-4.87M | 30.62%-3.42M | 24.45%-4.77M | 5.75%-4.72M |
| Net non-operating interest income (expenses) | 47.73%812.62K | 39.63%171.11K | 78.45%243.68K | 111.24%294.88K | -32.00%102.95K | 275.63%550.07K | 42.47%122.55K | 130.34%136.55K | 316.28%139.59K | 773.19%151.39K |
| Non-operating interest income | 47.73%812.62K | 39.63%171.11K | 78.45%243.68K | 111.24%294.88K | -32.00%102.95K | 173.13%550.07K | 42.47%122.55K | 111.67%136.55K | 316.28%139.59K | 773.19%151.39K |
| Other net income (expenses) | 102.20%113.48K | 48.81%-1.97M | 264.86%1.69M | -1,504.97%-2.12M | 1,853.67%2.52M | -297.08%-5.16M | -608.91%-3.86M | -154.49%-1.02M | -238.73%-132.12K | -840.57%-143.77K |
| Gain on sale of security | 102.20%113.48K | 48.81%-1.97M | 264.86%1.69M | -1,504.97%-2.12M | 1,853.67%2.52M | -297.08%-5.16M | -608.91%-3.86M | -154.49%-1.02M | -238.73%-132.12K | -840.57%-143.77K |
| Income before tax | -7.25%-24.01M | -0.00%-8.61M | -21.46%-5.23M | -64.34%-7.83M | 50.19%-2.35M | -8.01%-22.38M | -44.92%-8.61M | -23.07%-4.3M | 24.63%-4.76M | 5.20%-4.71M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -7.25%-24.01M | -0.00%-8.61M | -21.46%-5.23M | -64.34%-7.83M | 50.19%-2.35M | -8.01%-22.38M | -44.92%-8.61M | -23.07%-4.3M | 24.63%-4.76M | 5.20%-4.71M |
| Net income continuous operations | -7.25%-24.01M | -0.00%-8.61M | -21.46%-5.23M | -64.34%-7.83M | 50.19%-2.35M | -8.01%-22.38M | -44.92%-8.61M | -23.07%-4.3M | 24.63%-4.76M | 5.20%-4.71M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -7.25%-24.01M | -0.00%-8.61M | -21.46%-5.23M | -64.34%-7.83M | 50.19%-2.35M | -8.01%-22.38M | -44.92%-8.61M | -23.07%-4.3M | 24.63%-4.76M | 5.20%-4.71M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -7.25%-24.01M | -0.00%-8.61M | -21.46%-5.23M | -64.34%-7.83M | 50.19%-2.35M | -8.01%-22.38M | -44.92%-8.61M | -23.07%-4.3M | 24.63%-4.76M | 5.20%-4.71M |
| Diluted earnings per share | 5.26%-0.36 | 13.33%-0.13 | 0.00%-0.07 | -37.50%-0.11 | 50.00%-0.04 | 2.56%-0.38 | -50.00%-0.15 | -16.67%-0.07 | 38.46%-0.08 | 27.27%-0.08 |
| Basic earnings per share | 5.26%-0.36 | 13.33%-0.13 | 0.00%-0.07 | -37.50%-0.11 | 50.00%-0.04 | 2.56%-0.38 | -50.00%-0.15 | -16.67%-0.07 | 38.46%-0.08 | 27.27%-0.08 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting